Palomar Medical (PMTI) Surges After Home Anti-Wrinkle Devices Given FDA Okay
Tweet
Share
E-mailGet Alerts PMTI Hot Sheet
Join SI Premium – FREE
Shares of Palomar Medical Technologies Inc. (Nasdaq: PMTI) are surging higher after the company announced that it has become the first company to receive a 510(k) over-the-counter (OTC) clearance from the FDA for a new, patented, home use, laser device for the treatment of periorbital wrinkles. The stocks is up 41% in mid-day action.
CEO Joseph P. Caruso said, "This FDA clearance for a laser to treat wrinkles in the home opens up a tremendous opportunity to tap into the multi-billion dollar consumer skin care market with our patented technology."
CEO Joseph P. Caruso said, "This FDA clearance for a laser to treat wrinkles in the home opens up a tremendous opportunity to tap into the multi-billion dollar consumer skin care market with our patented technology."
You May Also Be Interested In
- EyePoint's DURAVYU misses primary endpoint in wet AMD trial
- Zai Lab and argenx report Phase 3 trial win for myositis drug
- Mesoblast completes patient treatment in phase 3 back pain trial
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
